GSK’s Shingrix Vaccine Can Reach Millions More

US FDA Clears New Claim In Immunocompromised Adults

Shingles vaccine
US FDA approves Shingrix for use in immunocompromised adults • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip